CGIBD Epi Conference - “Impact of Guideline Changes on Rates of Elective Surgery for Diverticulitis in the US” by Anne Peery, MD, MSCR
2018-09-12 16:00 - 17:00 (America/New_York) | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Impact of Guideline Changes on Rates of Elective Surgery for Diverticulitis in the US”
Anne Peery, MD, MSCR
Assistant Professor, Department of Medicine—GI & Hepatology

CGIBD Research Seminar - Cancelled due to Hurricane Florence
2018-09-13 16:30 - 17:30

CGIBD Epi Conference - “Navigating Clinical Data Resources from NC TraCS: The Carolina Data Warehouse for Health, Clinical Data Research Networks, i2b2@UNC, EMERSE, and CLARK” by Kellie Walters, MPH, DHES
2018-09-19 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Navigating Clinical Data Resources from NC TraCS: The Carolina Data Warehouse for Health, Clinical Data Research Networks, i2b2@UNC, EMERSE, and CLARK”
Kellie Walters, MPH, CHES
Sr. Informatics Project Manager
Biomedical Informatics Service NC TraCS Institute
University of North Carolina at Chapel Hill

CGIBD Research Seminar - “GI Pharmacoepidemiology @ UNC - Recent Examples" hosted by Til Stürmer, MD, PhD
2018-09-20 16:30 - 17:30 | Marsico Hall 2004
“GI Pharmacoepidemiology @ UNC – Recent Examples:
¨ Propensity Score Primer by Jeff Yang, PhD Student
¨ PPIs and Acute MI by Suzanne Landi, PhD, Epidemiologist, IQVIA
¨ DPP4i_IBD by Tiansheng Wang, PharmD, MsC, PhD Student
Hosted by: Til Stürmer, MD, PhD
Nancy A. Dreyer Distinguished Professor
Chair, Department of Epidemiology
Gillings School of Global Public Health
The University of North Carolina at Chapel Hill
Dr. Stürmer is an internist and epidemiologist with expertise in state of the art methods for nonexperimental treatment comparisons, including comparative effectiveness research. He has worked as a cancer epidemiologist, has over 15 year experience in analyzing claims data and merging claims data to other data sources, and is an internationally recognized leader in propensity scores and disease risk scores.
Conference Streamed Live: https://cgibd.my.webex.com
Meeting # 624 562 559
Audio: 1-510-338-9438

CGIBD Epi Conference - “Dipeptidyl peptidase-4 inhibitor use and incidence of inflammatory bowel disease among U.S. insured patients” by Jeff Yang, PhD Candidate
2018-09-26 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Dipeptidyl peptidase-4 inhibitor use and incidence of inflammatory bowel disease among U.S. insured patients”
Jeff Yang, PhD Candidate
Dept. of Epidemiology
School of Public Health

CGIBD Research Seminar - “Immunity and Persistence of the Hepatitis E Virus” by Christopher M. Walker, PhD
2018-09-27 16:30 - 17:30 | Marsico Hall 2004
“Immunity and Persistence of the Hepatitis E Virus”
Christopher M Walker, PhD
Professor
The Wilby S. Cowan Endowed Chair in Pediatric Research
Department of Pediatrics and Molecular Virology, Immunology
Department of Medical Genetics
The Ohio State University
The Research Institute at Nationwide Children’s Hospital
For the past 20 years we have focused primarily on immunity to the hepatitis C virus. More recently, we have studied immunity to the hepatitis E virus to better understand how it establishes persistence in humans with compromised immunity. To define protective immune responses, we have developed rhesus macaque models of acute and persistent HEV infection. Through these studies, Dr. Feng and I established a close working relationship to define the role of T cells and neutralizing antibodies in prevention of HEV persistence.
Conference Streamed Live: https://cgibd.my.webex.com
Meeting #: 624 562 559
Audio connection: 1-510-338-9438

CGIBD Epi Conference - “Secondary analysis of Patient-Reported Outcomes Project of HCV Target (PROP UP)” by Donna Evon, PhD
2018-10-03 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Introductions and Research Opportunities: Secondary analysis of Patient-Reported Outcomes Project of HCV Target (PROP UP)”
Donna Evon, PhD
Associate Professor
Department of Medicine, GI Division

CGIBD Research Seminar - “Porphyrin-triggered protein aggregation: mechanism and porphyria implications” by M. Bishr Omary, MD, PhD
2018-10-04 16:30 - 17:30 | Marsico Hall 2004
“Porphyrin-triggered protein aggregation: mechanism and porphyria implications”
M. Bishr Omary, MD, PhD
Executive Vice Dean for Research and Chief Scientific Officer
Professor of Molecular & Integrative Physiology and Internal Medicine
H Marvin Pollard Professor of Gastroenterology
University of Michigan Medical School
AGA Vice President (2018—2019) & President (2020-2021)
Dr. Omary’s research program involves basic, translational, and clinical studies focused on the function and regulation of intermediate filaments in GI biology and disease. The Omary lab is active in identifying and characterizing biomarkers for acute and chronic liver and pancreatic diseases, and pursuing molecular understanding of porphyria pathogenesis and related therapeutic approaches. Dr. Omary served as the editor-in-chief of the journal Gastroenterology (2011-2016) and is currently the chair of NIH Clinical, Integrative & Molecular Gastroenterology (CIMG) Study Section (2018-2020).
Conference Streamed Live: https://cgibd.my.webex.com
Meeting # 624 562 559
Audio: 1-510-338-9438

CGIBD Epi Conference - “How to write and get a career development award” by Robert S. Sandler, MD, MPH
2018-10-10 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“How to write and get a career development award”
Robert S. Sandler, MD, MPH
Nina C. and John T. Sessions Distinguished Professor
Director, Center for Gastrointestinal Biology and Disease

CGBID Research Seminar - Cancelled due to Hurricane Michael
2018-10-11 16:30 - 17:30

CGIBD Epi Conference - “WIP: Comparative effectiveness of treatment modalities for early stage hepatocellular carcinoma” by Hannah Kim, MD & Andrew Moon, MD, MPH
2018-10-17 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Work in progress: Comparative effectiveness of treatment modalities for early stage hepatocellular carcinoma”
Hannah Kim, MD
Clinical Fellow
Department of Medicine—Division of Gastroenterology
And
Andrew Moon, MD, MPH
Clinical Fellow
Department of Medicine—Division of Gastroenterology

CGIBD Research Seminar - No Seminar Today - Fall Break
2018-10-18 16:30 - 17:30

CGIBD Epi Conference - Two WIP Presentations
2018-10-24 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Work in progress: Analysis of opioid use following surgery for chronic pancreatitis”
Ted James, MD
Clinical Fellow
Department of Medicine—Division of Gastroenterology
And
“Work in progress: Understanding challenges, coping strategies & health behaviors among adult liver transplant recipients”
Sarah Lieber, MD
Clinical Fellow
Department of Medicine—Division of Gastroenterology

CGIBD Research Seminar - “Prebiotics for therapeutic modulation of the colonic microbiota ” by M. Andrea Azcarate-Peril, PhD
2018-10-25 16:30 - 17:30 | Marsico Hall 2004
“Prebiotics for therapeutic modulation of the colonic microbiota”
M.Andrea Azcarate-Peril, PhD
Associate Professor
Department of Medicine—Division of Gastroenterology and Hepatology
School of Medicine
Adjunct Associate Professor
Dept. of Nutrition
Gillings School of Global Public Health
Director, UNC Microbiome Core
The University of North Carolina at Chapel Hill
Adjunct Associate Professor
Dept. of Plant and Microbial Biology
North Carolina State University
Dr. Azcarate-Peril is a microbiologist by training and has extensive experience in the characterization of complex microbial populations and functional metagenomics using culture-dependent and culture-independent methods including Next Generation Sequencing. Her research projects have focused on functional genomics of probiotics and gut microbiome modulation by prebiotics for over 20 years, resulting in over 60 peer-reviewed publications.
Dr. Azcarate-Peril’s current projects aim to define modulators of the gut microbiome capable of reversing dysbioses induced by age, diet and nutritional behaviors. She is particularly interested in the development of application-directed probiotic strains to address and prevent gastrointestinal disorders.
Conference Streamed Live: https://cgibd.my.webex.com
Meeting # 624 562 559
Audio: 1-510-338-9438

CGIBD Epi Conference - Two Work in Progress presentations
2018-10-31 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Work in progress: Screening for squamous cell carcinoma of the aerodigestive tract”
Cary Cotton, MD, MPH
Clinical Research Fellow
Department of Medicine—Division of Gastroenterology
And
“Work in progress: The microbiota of gastric premalignant lesions: 16S sequencing data in a Central American population”
Michael Dougherty, MD
Clinical Research Fellow
Department of Medicine—Division of Gastroenterology

CGIBD Research Seminar - “The Pharyngeal Frontline: Divisions, Delaminations and Differentiation in Upper Aerodigestive Epithelia ” by Kevin Matthew Byrd, DDS, PhD
2018-11-01 16:30 - 17:30 | Marsico Hall 2004
“The Pharyngeal Frontline: Divisions, Delaminations and Differentiation in Upper Aerodigestive Epithelia ”
Kevin Matthew Byrd, DDS, PhD
Postdoctoral Research Associate
Dept. of Oral and Craniofacial Health Sciences
Surgical Resident
Graduate Training Program in Periodontology
School of Dentistry
The University of North Carolina at Chapel Hill
Dr. Byrd is a clinician-scientist. His research program is currently focused on 1) how the lining of the oral cavity protect the head and neck from microbes, toxins, and injury, 2) technologies for better post-operative wound healing and soft tissue grafting, and 3) beginning a collaborative project to begin building a human oral cell atlas for categorizing the unique and undiscovered cell types that contribute to oral and craniofacial diseases.
Conference Streamed Live: https://cgibd.my.webex.com
Meeting # 624 562 559
Audio: 1-510-338-9438
Password: [REDACTED]

CGIBD Epi Conference - “Designing a dietary intervention clinical trial in esophagitis” by Evan Dellon, MD, MPH
2018-11-07 08:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Designing a dietary intervention clinical trial in esophagitis”
Evan Dellon, MD, MPH
Associate Professor
Department of Medicine Division of Gastroenterology

CGIBD Research Seminar - “Mechanisms of Fibrosis in IBD” by Florian Rieder, MD
2018-11-08 16:30 - 17:30 | Marsico Hall 2004
“Mechanisms of Fibrosis in IBD”
Florian Rieder, MD
Associate Staff
Department of Gastroenterology, Hepatology and Nutrition
Digestive Diseases and Surgery Institute
Department of Inflammation and Immunity, Lerner Research Institute
Cleveland Clinic Foundation
Dr. Rieder’s focus is in the field of pathogenesis and prediction and trial endpoints of intestinal fibrosis. He has experience with primary human cell isolation and culture systems (endothelial cells, mesenchymal cells, immune cells, epithelial cells, preadipocytes/adipocytes) as well as animal models of intestinal fibrosis, including TNBS- and DSS-induced fibrosis. Dr. Rieder has designed and pursued prospective studies of diagnostic testing, cohort studies for biomarkers of complicated inflammatory bowel disease and retrospective chart review studies in the area of IBD. His life-time vision is to impact the field of intestinal fibrogenesis through by delivering a novel anti-fibrotic approach into a clinical setting.
Conference Streamed Live: https://cgibd.my.webex.com
Meeting #: 624 562 559
Audio connection: 1-510-338-9438
Meeting Password: [REDACTED]

CGIBD Epi Conference - Two presentations
2018-11-14 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
Work in Progress: “Screening for squamous cell carcinoma of the aerodigestive tract”
Cary Cotton, MD, MPH
Clinical Research Fellow
Department of Medicine—Division of Gastroenterology
And
“Strategizing DDW Submissions: An informal open discussion of topics to be submitted”
Sarah Lieber, MD
Clinical Research Fellow
Department of Medicine—Division of Gastroenterology

CGIBD Research Seminar - Cancelled today, please join us on November 29th
2018-11-15 16:30 - 17:30

CGIBD Research Seminar - No Seminar Today - Happy Thanksgiving!!!
2018-11-22 16:30 - 17:30

CGIBD Epi Conference - "Work in Progress" by Anne Peery, MD, MSCR
2018-11-28 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Work in Progress”
Anne Peery, MD, MSCR
Assistant Professor, Department of Medicine—GI & Hepatology

CGIBD Research Seminar - “Hepatocellular Carcinoma Surveillance: Gaps in Clinical Practice ” by Amit Singal, MD
2018-11-29 16:30 - 17:30 | Marsico Hall 2004
“Hepatocellular Carcinoma Surveillance: Gaps in Clinical Practice ”
Amit Singal, MD
David Bruton Professorship in Clinical Cancer Research
Department of Internal Medicine
University of Texas Southwestern Medical Center
Dr. Singal’s research interests include: the effectiveness of surveillance for hepatocellular carcinoma, the impact of patient and physician knowledge/attitudes on receipt of care and the quality of care in the cirrhotic patient.
Conference Streamed Live: https://cgibd.my.webex.com
Meeting #: 624 562 559
Audio connection: 1-510-338-9438
Meeting Password: [REDACTED]

CGIBD Epi Conference - “How to write a paper and get it published" by Robert S. Sandler, MD, MPH
2018-12-05 08:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“How to write a paper and get it published”
Robert S. Sandler, MD, MPH
Nina C. and John T. Sessions Distinguished Professor
Director, Center for Gastrointestinal Biology and Disease

CGIBD Research Seminar - “Characterizing the colonic and ileal mucosal bacterial community in Crohn’s disease ” by Terry Furey, PhD
2018-12-06 08:00 - 17:00 | Marsico Hall 2004
“Characterizing the colonic and ileal mucosal bacterial community in Crohn’s disease ”
Terry Furey, PhD
Associate Professor
Department of Genetics and the Department of Biology
The University of North Carolina at Chapel Hill
The Furey lab is interested in understanding IBD heterogeneity at the molecular and microbial levels. We use high throughput sequencing-based genomic assays to measure gene expression, chromatin accessibility, and microbial composition in tissue samples from well-phenotyped Crohn’s disease and non-IBD patients. With these, we aim to link unique molecular signatures with clinical variables to both uncover CD subtypes associated with disease phenotypes as well as begin elucidating potential cellular mechanisms driving disease.
Conference Streamed Live: https://cgibd.my.webex.com
Meeting #: 624 562 559
Audio connection: 1-510-338-9438
Meeting Password: [REDACTED]

CGIBD Epi Conference - "Work in Progress" by Matthew D. Egberg, MD, MPH, MMSc
2018-12-12 16:00 - 17:00 | Bioinformatics 4137, 130 Mason Farm Road, Chapel Hill, NC, 27599, United States
“Work in Progress”
Matthew D. Egberg, MD, MPH, MMSc.
Assistant Professor of Pediatrics
Division of Pediatric Gastroenterology and Hepatology

CGIBD Research Seminar - No seminar today due to exams
2018-12-13 16:30 - 17:30

CGIBD Research Seminar - No seminar today - Winter Break!
2018-12-20 16:30 - 17:30, 2018-12-27 08:00 - 17:00, 2019-01-03 16:30 - 17:30
